References
- Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–280
- Cox J. C., Yewdell J. W., Eisenlohr L. C., Johnson P. R., Bennink J. R. Antigen presentation requires transport of MHC class I molecules from endoplasmic reticulum. Science 1990; 247: 715–718
- Townsend A. R. M., Bodmer H. Antigen recognition by class I restricted lymphocytes. Ann Rev Immunol 1989; 7: 601–624
- Bevan M. J. Class discrimination in the world of immunology. Nature 1987; 325: 192–194
- Germain R. N. The ins and outs of antigen processing and presentation. Nature 1986; 322: 687–689
- Ridge J. P., Di Rosa F., Matzinger P. A. Conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998; 393: 474–478
- Bennett S. R. M., Carbone F. R., Karamalis F., Flavell R. A., Miller J. F. A. P., Heath W. R. Help for cytotoxic T-cell responses is mediated by CD40 signalling. Nature 1998; 393: 478–480
- Schoenberger S. P., Toes R. E. M., Van der Voort E. I. H., Offringa R., Melief C. J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998; 393: 480–483
- Almeida J. D., Edwards D. C., Brand C. M., Heath T. D. Formation of virosomes from influenza subunits and liposomes. Lancet 1975; 2: 899–901
- Wilschut J., Bron R. The influenza virus hemagglutinin:membrane fusion activity in intact virions and reconstituted virosomes. Viral fusion Mechanisms, J. Bentz. CRC Press, Boca Raton, FL 1993; 133–161
- Bron R., Ortiz A., Dijkstra J., Stegmann T., Wilschut J. Preparation, properties and applications of reconstituted influenza virus envelopes (virosomes). Methods in Enzymol. 1993; 220: 313–331
- Stegmann T., Morselt H. W. M., Booy F. P., Van Breemen J. F. L., Scherphof G., Wilschut J. Functional reconstitution of influenza virus envelopes. EMBO J. 1987; 6: 2651–2658
- Glück R., Mischler R., Finkel B., Que J. U., Scarpa B., Cryz S. J. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994; 344: 160–163
- Ando S., Tsuge H., Mayumi T. Preparation of influenza virosome vaccine with muramyldipeptide derivative B30-MDP. J. Microencaps. 1997; 14: 79–90
- Boudreault A., Thibodeau L. Mouse response to influenza immunosomes. Vaccine 1985; 3: 231–234
- El Guink N., Kris R. M., Goodman-Snitkoff G., Small P. A., Jr., Mannino R. J. Intranasal immunization with proteoliposomes protects against influenza. Vaccine 1989; 7: 147–151
- Bron R., Ortiz A., Wilschut J. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted influenza virus envelopes (virosomes). Biochemistry 1994; 33: 9110–9117
- Dijkstra J., Bron R., Wilschut J., De Haan A., Ryan J. L. Activation of murine lymphocytes by polysaccharide incorporated in fusogenic, reconstituted influenza virus envelopes (virosomes). J. Immunol. 1996; 157: 1028–1036
- Arkema J. M. S., Huckriede A., Schoen P., Wilschut J. C., Daemen T. Induction of cytotoxic T ymphocyte activity by fusion-active peptide-containing virosomes. Vaccine 2000; 18: 1327–1333